Cetuximab cuts progression risk by 15% in CRYSTAL trial: Commentary Journal Article
| Author: | Lichtman, S. M. |
| Article Title: | Cetuximab cuts progression risk by 15% in CRYSTAL trial: Commentary |
| Keywords: | protein expression; treatment response; clinical trial; disease course; drug tolerability; histopathology; salvage therapy; fluorouracil; cancer combination chemotherapy; drug efficacy; drug safety; monotherapy; patient selection; drug approval; skin manifestation; disease free survival; colorectal cancer; bolus injection; metastasis; epidermal growth factor receptor; combination chemotherapy; continuous infusion; cetuximab; irinotecan; drug hypersensitivity; cancer inhibition; liver metastasis; correlation analysis; folinic acid; intermethod comparison; short survey; colorectal surgery; risk reduction |
| Journal Title: | The Oncology Report |
| Issue: | Fall |
| ISSN: | 1548-5323 |
| Publisher: | International Medical News Group LLC |
| Date Published: | 2007-09-01 |
| Start Page: | 35 |
| End Page: | 36 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 17 November 2011" - "Source: Scopus" |
MSK Authors
-
228Lichtman